Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q2 2016 · 10-Q
Revenue$120.91M$120.91M+8.0% vs Q2 2015 Net Income$25.85M$25.85M−22.2% vs Q2 2015 EPS Diluted$0.69$0.69−22.5% vs Q2 2015 Gross Profit$81,587,000+7.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$38,539,000+7.9% Free Cash Flowderived$33,652,000+3.3% Margins · derivedGross margin67.5%−0.2 pt vs Q2 2015
Operating margin29.8%−1.1 pt vs Q2 2015
Net margin21.4%−8.3 pt vs Q2 2015
ended Dec 31, 2015 · filed Feb 9, 2016 · 40 d after period end